The pharmaceutical excipients market would grow at a CAGR of 5.39% over the predicted time frame. The market is expected to increase in value from US$ 9.33 Bn in 2022 to US$ 14.2 Bn in 2030.
The on pharmaceutical
excipients Market, which provides a business strategy, research &
development activities, concise outline of the market valuation, valuable
insights pertaining to market share, size, supply chain analysis, competitive
landscape and regional proliferation of this industry.
Download
Free Sample@ https://www.precedenceresearch.com/sample/1761
Report Scope of the Pharmaceutical Excipients Market
| Report Coverage | Details |
| Market Size by 2030 | USD 14.2 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 5.39% |
| Largest Market | North America |
| Fastest Growing Market | Europe |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, Functionality, Formulations, End-Users, Distribution Channel, Geography |
| Companies Mentioned | Ashland Global Holdings, BASF SE, DuPont, Roquette Feres, Evonik Industries AG, Associated British Foods, Archer Daniels Midland Company, Lubrizol Corporation, Croda International, Kerry Group |
A recent
report provides crucial insights along with application based and forecast
information in the Global Pharmaceutical excipients Market. The report provides
a comprehensive analysis of key factors that are expected to drive the growth
of this market. This study also provides a detailed overview of the
opportunities along with the current trends observed in the Pharmaceutical
excipients market.
A
quantitative analysis of the industry is compiled for a period of 10 years in
order to assist players to grow in the market. Insights on specific revenue
figures generated are also given in the report, along with projected revenue at
the end of the forecast period.
Companies
and Manufacturers Covered
The study
covers key players operating in the market along with prime schemes and
strategies implemented by each player to hold high positions in the industry.
Such a tough vendor landscape provides a competitive outlook of the industry,
consequently existing as a key insight. These insights were thoroughly analysed
and prime business strategies and products that offer high revenue generation
capacities were identified. Key players of the global Pharmaceutical excipients
market are included as given below:
Pharmaceutical excipients Market Key Players
- Ashland Global Holdings
- BASF SE
- DuPont
- Roquette Feres
- Evonik Industries AG
- Associated British Foods
- Archer Daniels Midland Company
- Lubrizol Corporation
- Croda International
- Kerry Group
Market Segments
- Organic Chemicals
- Inorganic Chemicals
- Others
By Functionality
- Fillers and Diluents
- Suspending and Viscosity Agents
- Coating Agents
- Binders
- Disintegrants
- Colorants
- Lubricants and Glidants
- Preservatives
- Emulsifying Agents
- Flavoring Agents and Sweeteners
- Other Functionalities
By Formulations
- Topical Formulations
- Oral Formulations
- Parenteral Formulations
- Other Formulations
By End-Users
- Pharmaceuticals Companies
- Research Organization
- Academics
- Others
By Distribution Channel
- Online Pharmacy
- Retail
- Mail-Order
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Report Objectives
- To define, describe, and forecast the global pharmaceutical
excipients market based on product, and region
- To provide detailed information regarding the major
factors influencing the growth of the market (drivers, opportunities, and
industry-specific challenges)
- To strategically analyze micromarkets1 with respect to
individual growth trends, future prospects, and contributions to the total
market
- To analyze opportunities in the market for stakeholders
and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to
four main regions—North America,
Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively
analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as
acquisitions, expansions, new product launches, and partnerships in the pharmaceutical
excipients market
Table of Content
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Pharmaceutical Excipients Market
5.1. COVID-19 Landscape: Pharmaceutical Excipients Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Pharmaceutical Excipients Market, By Product
8.1. Pharmaceutical Excipients Market, by Product, 2022-2030
8.1.1. Organic Chemicals
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Inorganic Chemicals
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Pharmaceutical Excipients Market, By Functionality
9.1. Pharmaceutical Excipients Market, by Functionality, 2022-2030
9.1.1. Fillers and Diluents
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Suspending and Viscosity Agents
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Coating Agents
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Binders
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Disintegrants
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Colorants
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Lubricants and Glidants
9.1.7.1. Market Revenue and Forecast (2017-2030)
9.1.8. Preservatives
9.1.8.1. Market Revenue and Forecast (2017-2030)
9.1.9. Emulsifying Agents
9.1.9.1. Market Revenue and Forecast (2017-2030)
9.1.10. Flavoring Agents and Sweeteners
9.1.10.1. Market Revenue and Forecast (2017-2030)
9.1.11. Other Functionalities
9.1.11.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Pharmaceutical Excipients Market, By Formulations
10.1. Pharmaceutical Excipients Market, by Formulations, 2022-2030
10.1.1. Topical Formulations
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Oral Formulations
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Parenteral Formulations
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.3. Other Formulations
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Pharmaceutical Excipients Market, By End-Users
11.1. Pharmaceutical Excipients Market, by End-Users, 2022-2030
11.1.1. Pharmaceuticals Companies
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Research Organization
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Academics
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Other
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Pharmaceutical Excipients Market, By Distribution Channel
12.1. Pharmaceutical Excipients Market, by Distribution Channel, 2022-2030
12.1.1. Online Pharmacy
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Retail
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Mail-Order
12.1.3.1. Market Revenue and Forecast (2017-2030)
12.1.4. Others
12.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Pharmaceutical Excipients Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.1.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.1.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.1.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.1.6.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.1.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.8.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.1.8.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.1.8.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.1.8.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.2.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.2.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.2.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.2.7. Market Revenue and Forecast, by End-Users (2017-2030)
13.2.8. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.2.10. Market Revenue and Forecast, by End-Users (2017-2030)
13.2.11. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.12.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.2.12.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.2.12.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.2.13. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.14.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.2.14.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.2.14.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.2.15. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.3.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.3.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.3.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.3.6.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.3.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.3.8.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.3.9. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.3.10.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.3.10.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.11.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.3.11.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.3.11.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.3.11.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.4.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.4.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.4.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.4.6.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.4.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.4.8.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.4.9. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.4.10.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.4.10.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.11.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.4.11.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.4.11.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.4.11.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.5.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.5.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.5.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.5.6.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.5.7. Market Revenue and Forecast, by Distribution Channel (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Functionality (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Formulations (2017-2030)
13.5.8.4. Market Revenue and Forecast, by End-Users (2017-2030)
13.5.8.5. Market Revenue and Forecast, by Distribution Channel (2017-2030)
Chapter 14. Company Profiles
14.1. Ashland Global Holdings
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. BASF SE
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. DuPont
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Roquette Feres
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Evonik Industries AG
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Associated British Foods
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Archer Daniels Midland Company
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Lubrizol Corporation
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Croda International
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Kerry Group
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments